Investigating tau pathology and rCBF simultaneously by using dynamic [18F]flortaucipir PET might yield valuable information, since both pathophysiological mechanisms may contribute to cognitive impairment in AD. The gene discussed is MAPT; the disease is Alzheimer disease.